ATANIS Biotech completes Financing Round
ATANIS Biotech, a Swiss biotechnology company specializing in advanced allergy diagnostics, has successfully completed an oversubscribed financing round led by Spectrum Moonshot Fund and supported by experienced investors in the allergy field.
VISCHER advises Kelun-Biotech, Harbour BioMed and RTW Investments in USD 200m Series A Financing of Windward Bio
Windward Bio Group AG, a Basel-based private, clinical-stage, drug development company committed to improving outcomes for people living with advanced immunological diseases, announced its launch with a USD 200m series A financing from lead investors OrbiMed, Novo Holdings and Blue Owl Healthcare Opportunities, and co-investors SR One, Omega Funds, RTW Investments, Qiming Venture Partners, Quan Capital and Pivotal bioVenture Partners.
Avenir Group enters into strategic partnership with Liberta Partners
Avenir Group, a leading company in the development and implementation of integrated services and solutions in human resource management, enters into a strategic partnership with Liberta Partners, a Munich-based multi-family office.
Santis Pharma receives investment from Abenex
The founders of Santis Pharma, a Franco-Swiss laboratory company developing and marketing food supplements with health benefits, have entered into a partnership with Abenex, a French private equity investor.
FIT Voltaira Group acquires Auto-Kabel Group
FIT Voltaira Group, a leading supplier of sensor, connectivity, and electrification solutions, announced the acquisition of the globally operating Auto-Kabel Group, a pioneer in e-mobility.
Cisco to acquire Isovalent
Cisco (NASDAQ: CSCO) intends to acquire Isovalent, a leader in open source cloud native networking and security, to bolster its secure networking capabilities across public clouds
Lallemand subsidiary Danstar Ferment AG takes over Evolva AG
On 28 December 2023, Danstar Ferment AG, a Swiss subsidiary of Canadian multi-national, Lallemand Inc., has successfully completed the acquisition of Swiss based Evolva AG, subsidiary of SIX listed Evolva Holding SA.
VISCHER advises Bregal on the acquisition of Netrics Group
Funds advised by Bregal Unternehmerkapital acquire Netrics Group, one of the largest cloud and modern workplace providers in Switzerland, from Waterland Private Equity. The transaction is accompanied by a reinvestment of the...
ATANIS Biotech AG completes Financing Round
ATANIS Biotech AG, a Swiss biotechnology company specializing in functional allergy diagnosis, announced the successful completion of a significant capital increase.
BlackSheep MadTech Fund invests in Nexoya AG
BlackSheep MadTech Fund, managed by EUREKA! Venture SGR, the first European venture capital fund with an entrepreneurial background that invests in the marketing and advertising technology industry, has been the lead investor in the USD 5m series A investment round of Nexoya AG, a Swiss marketing analytics start up.